Baiyunshan Pharma Schedules First Extraordinary General Meeting of 2026 to Approve Directors’ Remuneration Measures

Bulletin Express
08/07

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited has issued a proxy form for its first extraordinary general meeting (EGM) of 2026, set for 10:00 a.m. on Friday, 28 August 2026, at the company’s headquarters on No. 45 Sha Mian North Street, Liwan District, Guangzhou, Guangdong Province, China.

Two ordinary resolutions will be put to a shareholder vote:

1. Adoption of the Remuneration Management Measures for Directors and Senior Management. 2. Confirmation of the 2026 remuneration package for employee-representative director Mr. Liu Hong.

Shareholders may appoint the EGM chair or another individual as proxy and are required to submit signed proxy forms—together with any notarised power of attorney, if applicable—to the company’s H-share registrar, Computershare Hong Kong Investor Services Limited, no later than 24 hours before the meeting. Joint shareholders must ensure the proxy form is signed by the first-named holder on the share register.

Attendance in person overrides any previously submitted proxy. All times referenced follow Hong Kong time.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10